drugset / Trial / NCT00002955
Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
Phase 2
Completed
21 enrolled
University of Southern California
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with advanced cancer of the pancreas.
Timeline
- Start
- 1995-08
- Primary completion
- 2000-05
- Completion
- 2006-06
Publications
- Results Garcia AA, Leichman L, Baranda J, et al.: Phase II study of trimetrexate (neutrexin), 5-fluorouracil and leucovorin (NFL) in advacne pancreatic. [Abstract] Proceedings of the American Society of Clinical Oncology 18: A971, 253a, 1999.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucovorin | Small molecule | — | Intravenous |
| Subject | Trimetrexate | Unknown | — | Intravenous |
| Subject | fluorouracil | Small molecule | — | Intravenous |